Bonus Biogroup
Matam Advanced Techn ,Haifa 31905,Israel
Gallery
Business Details
At Bonus Biogroup, we are pioneering the future of regenerative medicine. Our groundbreaking technologies and innovative approach are bound to help millions live better and longer lives
Bonus Biogroup (TASE: BONS) is an advanced clinical-stage biotechnology company developing 'next-generation' therapies for a variety of indications in the regenerative medicine field. As pioneers in the industry, we leverage our extensive knowledge and expertise to establish a unique technological platform, which underpins the development of our leading products, BonoFill™ and MesenCure™.
Our Vision
Bonus Biogroup strives to Empower millions of patients to live healthier and longer lives through scientific leadership and excellence, technological innovation, and a patient-centric approach.
Our mission
We aim to develop and deliver safe, effective, and affordable tissue engineering and cell therapy products to address severe conditions representing multi-billion-dollar markets with limited treatment options.
- Type:
- Manufacturer/producer
- Establishment year:
- 2008
Videos
Team
Team
Shai Meretzki, Ph.D.
Founder and CEO
Dr. Meretzki is a seasoned leader in the Life Science field, having founded several biotech companies, including Pluristem, where he served as CEO and CTO. He holds a Ph.D. in biotechnology from the Technion - Israel Institute of Technology, in collaboration with the Weizmann Institute of Science, Israel. His proven operational, management, and lea
Yoni Livne, CPA
Chief Financial Officer
Mr. Livne has been instrumental in shaping Bonus Biogroup's financial strategy since 2014. Prior to joining the company, he served as CFO at Bee Contact Communication Ltd., a publicly-traded company (TASE), and as Chief Controller at Dexcel Pharma, a leading international pharmaceutical company. With an MBA in Finance and a BA in Accounting and Eco
Dror Ben David, Ph.D.
Chief Operations Officer.
Dr. Ben-David oversees all of Bonus Biogroup's operations, bringing his extensive experience in R&D and operations management to the role. He has been instrumental in the development of all of Bonus Biogroup’s innovative products. With a Ph.D. in medical sciences from the Technion Faculty of Medicine and a specialization in adult stem cells, Dr. Be
Vered Kivity, Ph.D.
VP Regulatory & Clinical Affairs
Dr. Kivity brings a wealth of experience in global regulatory and clinical affairs to Bonus Biogroup. With a strong background in pharma, biotech, and medical device companies, she has successfully led submissions to regulatory authorities worldwide. Holding a Ph.D. and MBA degrees from the Technion, the Israeli Institute of Technology, Dr. Kivity
Atara Novak, Ph.D.
VP Research & Development
Dr. Atara Novak spearheads Bonus Biogroup's R&D operations. With 15 years of experience in Stem Cells and over ten years in cell therapy, she is a leader in her field. Holding a Ph.D. from the Technion Faculty of Medicine, Dr. Novak is at the forefront of translating scientific breakthroughs into advanced biotechnologies. Her leadership ensures the
Corinne Chemouny, Pharm.D
VP Quality Assurance
Dr. Corinne Chemouny, our VP of Quality Assurance, brings over 20 years of experience in aseptic manufacturing, GMP, and Quality Affairs. She completed her residency in France and served as Pharmacist-in-Charge at Taro Pharmaceuticals before joining Bonus Biogroup. Her extensive experience ensures the highest standards of quality in our operations.
Tomer Bronshtein, Ph.D.
VP Business Development
Dr. Tomer Bronshtein, our VP of Business Development, has over 15 years of experience in R&D and translating Next Generation Therapies. He is instrumental in identifying and developing opportunities to increase Bonus Biogroup's value for patients, healthcare providers, and strategic partners. Additionally, he is responsible for planning and managin
Map Location
BUSINESS REVIEWS
There are no reviews at the moment
Owner profile
Matam Advanced Techn ,Haifa 31905,Israel
Bonus Biogroup
At Bonus Biogroup, we are pioneering the future of regenerative medicine. Our groundbreaking technologies and innovative approach are bound to help millions live better and longer lives